Funder: American Cancer Society
Due Dates: June 2, 2025 | December 1, 2025
Funding Amounts: Stage I: Up to $297,000 total over 2 years (direct + 10% indirect costs) | Stage II: Up to $599,500 total over 18 months (direct + 10% indirect costs)
Summary: Supports translational cancer research projects moving toward human testing, with staged funding for milestone development and clinical studies in patients.
Key Information: Stage II applications require prior completion of Stage I milestones; open to independent investigators at any career stage.